Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

doi:10.4254/wjh.v16.i1.41

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2715)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

WORD

HTML

1594

Figures (1-4)

242

Tables (1-3)

223

Sum=2160

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

136

Download

335

Sum=471

Jan 27, 2024 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Jan 27, 2024; 16(1): 41-53
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.41

Full Size Figure Download Figure

Figure 4 Cumulative incidence and Survival probability of hepatocellular carcinoma between the direct-acting antiviral agents treatment group and the non-antiviral treatment group. A: Cumulative incidence of hepatocellular carcinoma (HCC) between direct-acting antiviral agents (DAAs) treatment group and non-antivial treatment group; B: Survival probability of HCC between new DAAs treatment group and non-antivial treatment group.

Citation: Tao XM, Zeng MH, Zhao YF, Han JX, Mi YQ, Xu L. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study. World J Hepatol 2024; 16(1): 41-53
URL: https://www.wjgnet.com/1948-5182/full/v16/i1/41.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i1.41